Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorderRecruitingPhase 1 / Phase 22026-09-25NCT06800313

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Janssen Research & Development, LLC188

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Associated Medical ProfessionalsSyracuseUnited States8
Carolina Urologic Research CenterMyrtle BeachUnited States55
Dana Farber Mass General Brigham Cancer Care IncBostonUnited States1
Duke University Medical CenterDurhamUnited States505
Florida Cancer SpecialistsSarasotaUnited States47
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterLong Island CityUnited States3
NEXT OncologyAustinUnited States8
Rocky Mountain Cancer CenterColorado SpringsUnited States1
Sarah Cannon Research InstituteNashvilleUnited States119
Sarah Cannon Research Institute 1DenverUnited States1
South Texas Accelerated Research Therapeutics, LLC (START)Grand RapidsUnited States1
The Royal Marsden NHS TrustSuttonUnited Kingdom1
Urology AssociatesNashvilleUnited States10
Urology Cancer Center, PCOmahaUnited States3
Virginia Clinical ResearchNorfolkUnited States2
XCancer Research Network LCMC Health EJGHMetairieUnited States1
Yale UniversityNew HavenUnited States44